BOJ Minutes Reveal Growing Debate Over Interest Rate Hikes and Inflation Risks 
U.S. Stocks Rally to Record Highs as AI Rebound Fuels Holiday-Shortened Session 
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program 
Oil Prices Edge Higher as Strong U.S. Growth and Supply Risks Support Market 
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss 
Gold Price Breaks $4,500 as Safe-Haven Demand and Rate Cut Bets Fuel Rally 
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market 
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling 
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate 
Eli Lilly’s Weight-Loss Pill Nears Fast-Track FDA Approval as Profits Surge on Global Demand 
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares 
Pfizer Secures $10 Billion Deal for Obesity Drug Developer Metsera, Outbids Novo Nordisk 
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease 
IMF Reaches Staff-Level Agreement With Egypt, Opening Path to $3.8 Billion in Funding 
Pfizer Boosts Bid for Metsera Amid Intensifying Rivalry with Novo Nordisk in Obesity Drug Market 
MBK Partners has acquired a 99.5 percent stake in Medit, a Seoul-based 3D dental scanner and solutions provider, from its largest shareholder, Unison Capital for 2.4 trillion won.
The acquisition took place a month after MBK was selected as the preferred bidder over the world's renowned private equity and investment firms, such as Carlyle, KKR, and Blackstone.
Medit founder Jang Min-ho and the firm's specially related parties also agreed to reinvest a considerable amount of revenue into the company. They will remain as joint investors with MBK. The deal is expected to close sometime around the first quarter of 2023.
The acquisition took place amid projections of the dental scanner market here and abroad growing 30 percent each year until 2027.
Medit is a global leader in the market for dental scanner solutions. The company secured a market share of 22 percent in 2020, and the portion rose to 24 percent this year.
The Korean firm started expanding its global footing in the industry from 2018 and has so far established branches in major countries such as the United States, Germany and China. The company runs 230 dealerships in around 100 countries across the globe.
Medit generated sales of 190.5 billion won last year, but this year's sales are estimated to have soared to around 270 billion won.
The dental scanner industry was an oligopoly market, with a group of top five companies accounting for more than 85 percent of the total market share. But the investment banking industry forecasts Medit and 3Shape to continue to expand their dominance in the industry and intensify a two-way rivalry.
